scispace - formally typeset
C

Christopher M. Mulligan

Researcher at Colorado State University

Publications -  7
Citations -  177

Christopher M. Mulligan is an academic researcher from Colorado State University. The author has contributed to research in topics: Docosahexaenoic acid & Cardiolipin. The author has an hindex of 6, co-authored 7 publications receiving 147 citations.

Papers
More filters
Journal ArticleDOI

Delta-6-desaturase links polyunsaturated fatty acid metabolism with phospholipid remodeling and disease progression in heart failure.

TL;DR: A pivotal role of essential fatty acid metabolism in myocardial phospholipid remodeling induced by hemodynamic stress is demonstrated and novel links between this phenomenon and the propagation of multiple pathogenic systems involved in maladaptive cardiac remodeling and contractile dysfunction are revealed.
Journal ArticleDOI

Inhibition of Delta-6 Desaturase Reverses Cardiolipin Remodeling and Prevents Contractile Dysfunction in the Aged Mouse Heart Without Altering Mitochondrial Respiratory Function

TL;DR: Interestingly, delta-6 desaturase inhibition had no effect on age-related mitochondrial respiratory dysfunction, H2O2 release, or lipid peroxidation but markedly attenuated cardiac dilatation, hypertrophy, and contractile dysfunction in aged mice.
Journal ArticleDOI

The role of dietary fatty acids in predicting myocardial structure in fat-fed rats.

TL;DR: Under conditions of high-fat feeding, replacement of 10% saturated fat with either LA or ALA is associated with thickening of the cranial LV wall, but without concomitant functional changes.
Journal ArticleDOI

Tafazzin deficiency impairs CoA-dependent oxidative metabolism in cardiac mitochondria.

TL;DR: These findings support links among cardiolipin abnormalities, respiratory supercomplex instability, and mitochondrial oxidant production and shed new light on the distinct metabolic consequences of tafazzin deficiency in the mammalian heart.